Kamyar Kalantar-Zadeh M.D. to Randomized Controlled Trials as Topic
This is a "connection" page, showing publications Kamyar Kalantar-Zadeh M.D. has written about Randomized Controlled Trials as Topic.
Connection Strength
1.218
-
Observational studies versus randomized controlled trials: avenues to causal inference in nephrology. Adv Chronic Kidney Dis. 2012 Jan; 19(1):11-8.
Score: 0.370
-
Effect of Bimagrumab on body composition: a systematic review and meta-analysis. Aging Clin Exp Res. 2024 Sep 09; 36(1):185.
Score: 0.223
-
Sucroferric oxyhydroxide for hyperphosphatemia: a review of real-world evidence. J Nephrol. 2022 04; 35(3):875-888.
Score: 0.186
-
Low-protein diet for conservative management of chronic kidney disease: a systematic review and meta-analysis of controlled trials. J Cachexia Sarcopenia Muscle. 2018 04; 9(2):235-245.
Score: 0.139
-
The extinguished BEACON of bardoxolone: not a Monday morning quarterback story. Am J Nephrol. 2013; 37(3):208-11.
Score: 0.100
-
Let them eat during dialysis: an overlooked opportunity to improve outcomes in maintenance hemodialysis patients. J Ren Nutr. 2013 May; 23(3):157-63.
Score: 0.099
-
Does delivering more dialysis improve clinical outcomes? What randomized controlled trials have shown. J Nephrol. 2022 06; 35(5):1315-1327.
Score: 0.046
-
Cardiovascular and Renal Outcomes Trials-Is There a Difference? Am J Cardiol. 2015 Sep 15; 116(6):982-8.
Score: 0.029
-
Glycated hemoglobin and risk of death in diabetic patients treated with hemodialysis: a meta-analysis. Am J Kidney Dis. 2014 Jan; 63(1):84-94.
Score: 0.026